methyl-benzoyl-CoA | 1144034-16-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl-benzoyl-CoA
• 英文别名: S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-methylbenzenecarbothioate
• CAS: 1144034-16-1
• 化学式: C₂₉H₄₂N₇O₁₇P₃S
• 分子量: 885.676
• InChiKey: ATOBVMVSPXOGBP-SXQYHYLKSA-N

物化性质

• 密度：
  1.79±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -3.6
• 重原子数：
  57
• 可旋转键数：
  21
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  389
• 氢给体数：
  9
• 氢受体数：
  22

反应信息

• 作为反应物：
  描述：

  methyl-benzoyl-CoA 在 titanium(III) citrate 、 methyl-BzCoA reductase Tcl 作用下， 以 aq. buffer 为溶剂， 生成 、
  参考文献：
  名称：

  一种催化多功能的苯甲酰基-CoA还原酶，是反硝化细菌中甲基和卤代苯甲酸酯降解的关键酶。

  摘要：

  I类苯甲酰辅酶A（BzCoA）还原酶（BCR）是芳香族化合物厌氧降解的关键酶。他们可能通过基于自由基的，类似桦木的还原机制催化中央BzCoA中间体及其类似物向ATP依赖性还原成共轭环状1,5-二烯酰基-CoA。于1995年发现的反硝化细菌芳香龙虾（BCRTar）的酶至今仍是唯一分离出的且可从生物化学途径获得的BCR，主要是因为BCR极不稳定，并且迄今为止其异源生产已大大失败。这里，我们描述了一个平台，用于从大肠杆菌中的相关反硝化物种Thauera chlorobenzoica（MBRTcl）编码指定的3-甲基苯甲酰辅酶A还原酶的四个结构基因的异源表达。有人建议参与降解甲基取代的BzCoA类似物。重组的MBRTcl具有一个αβγδ亚基结构，包含三个低电势[4Fe-4S]簇，并且高度不稳定。它催化了BzCoA的ATP依赖性还原脱芳香化反应，每转移两个电子就水解2.3-2.8个ATP，并优先在间

  DOI：

  10.1074/jbc.ra118.003329
• 作为产物：
  描述：

  对甲苯甲酸 、 辅酶 A 在 benzoate-CoA ligase from rhodopseudomonas Palustri 、 5’-三磷酸腺苷 、 magnesium chloride 作用下， 反应 24.0h， 生成 methyl-benzoyl-CoA
  参考文献：
  名称：

  建立用于前体导向的聚酮化合物生物合成的工具包：探索酸性CoA利加斯的底物混杂

  摘要：

  聚酮化合物是化学上多样化且具有医学上重要意义的生物化学物质，它们是通过聚酮化合物合酶从酰基辅酶A前体生物合成的。聚酮化合物的组合生物合成的局限性之一是缺少工具包，该工具包描述了递送聚酮化合物生物合成所必需的新型酰基-CoA前体的方法。使用从各种植物和微生物中获得的5种酸性CoA连接酶，我们通过针对123种羧酸的文库筛选每种酸性CoA连接酶，生物合成了79种酰基CoA硫酯的初始文库。酰基-CoA硫酯库包括肉桂基-CoA，3-苯基丙酰基-CoA，苯甲酰基-CoA，苯乙酰基-CoA，丙二酰-CoA，饱和和不饱和脂族CoA硫酯和双环芳族CoA硫酯的衍生物。在我们对新型酰基辅酶A前体的生物合成路线的搜索中，我们发现了两种以前未报道过的丙二酰辅酶A衍生物（3-硫代苯丙氨酰辅酶A和苯基丙二酰辅酶A），无法通过规范的丙二酰辅酶A合成酶生产。该报告强调了确定常规底物池之外底物混杂的实用性和重要性，并描述了建

  DOI：

  10.1021/bi300425j

文献信息

• Enediyne Antitumor Antibiotic Maduropeptin Biosynthesis Featuring a <i>C</i>-Methyltransferase That Acts on a CoA-Tethered Aromatic Substrate
  作者：Jianya Ling、Geoffrey P. Horsman、Sheng-Xiong Huang、Yinggang Luo、Shuangjun Lin、Ben Shen

  DOI：10.1021/ja1050814

  日期：2010.9.15

  The enediyne antitumor antibiotic maduropeptin (MDP) is produced by Actinomadura madurae ATCC 39144. The biosynthetic pathway for the 3,6-dimethylsalicylic acid moiety of the MDP chromophore is proposed to be comprised of four enzymes: MdpB, MdpB1, MdpB2, and MdpB3. Based on the previously characterized biosynthesis of the naphthoic acid moiety of neocarzinostatin (NCS), we expected a biosynthetic

  烯二炔抗肿瘤抗生素 maduropeptin (MDP) 由 Actinomadura madurae ATCC 39144 生产。 MDP 生色团的 3,6-二甲基水杨酸部分的生物合成途径被提议由四种酶组成：MDPB、MDPB1、MDPB2 和 MDPB3。基于先前表征的新制癌素 (NCS) 萘甲酸部分的生物合成，我们预期了一种生物合成途径，其特征是 MDPB2 CoA 连接酶在与烯二炔核心中间体偶联之前立即激活羧酸。令人惊讶的是，MDP 芳香酸生物合成途径采用了一种不寻常的逻辑，其中 MDPB2 催化的 CoA 活化发生在 MDPB1 催化的 C-甲基化之前，这表明 MDPB1 显然具有独特的能力，即 C-甲基化与 CoA 相连的芳香酸。
• Point Mutations (Q19P and N23K) Increase the Operational Solubility of a 2α-<i>O</i>-Benzoyltransferase that Conveys Various Acyl Groups from CoA to a Taxane Acceptor
  作者：Irosha N. Nawarathne、Kevin D. Walker

  DOI：10.1021/np900524d

  日期：2010.2.26

  Two site-directed Mutations within the wild-type 2-O-benzoyltransferase (tbt) cDNA, from Taxus cuspidata plants, yielded air encoded protein containing replacement amino acids at Q19P and N23K that trial) to a solvent-exposed loop region. The likely significant changes in the biophysical properties invoked by these mutations Caused the overexpressed, modified TBT (mTBT) to partition into the Soluble enzyme fraction about 5-fold greater than the wild-type enzyme. Sufficient protein could now be acquired to examine the scope of the substrate specificity of mTBT by incubation with 7,13-O,O-diacetyl-2-O-debenzoylbaceatin III that was mixed individually with various substituted benzoyls, alkanoyls, and (E)-butenoyl CoA donors. The mTBT catalyzed the conversion of each 7,13-O,O-diacetyl-2-O-debenzoylbaccatin III to several 7,13-O,O-diacetyl-2-O-acyl-2-O-debenzoylbaccatin III analogues. The relative catalytic efficiency of mTBT with the 7,13-O,O-diacetyl-2-O-debenzoyl surrogate Substrate and heterole carbonyl CoA substrates was slightly greater than with the natural aroyl substrate benzoyl CoA, While substituted benzoyl CoA thioesters were less productive. Short-chain hydrocarbon carbonyl and cyclohexanoyl CoA thioesters were also productive, where C-4 Substrates were transferred by mTBT with similar to 10- to 17-fold greater catalytic efficiency compared to the transfer of benzoyl. The described broad specificity of mTBT suggests (flat a plethora of 2-O-acyl variants of the antimitotic paclitaxel can be assembled through biocatalytic sequences.
• MICROORGANISMS AND METHODS FOR THE PRODUCTION OF 1.4- CYCLOHEXANEDIMETHANOL
  申请人：Genomatica, Inc.

  公开号：EP2652141A1

  公开（公告）日：2013-10-23
• [EN] MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE<br/>[FR] MICROORGANISMES ET PROCÉDÉ DE BIOSYNTHÈSE D'HYDROCARBURES AROMATIQUES 2,4-PENTADIENOATE ET 1,3-BUTADIÈNE
  申请人：GENOMATICA INC

  公开号：WO2012018624A2

  公开（公告）日：2012-02-09

  The invention provides non-naturally occurring microbial organisms having a toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-lol or 1,3-butadiene pathway. The invention additionally provides methods of using such organisms to produce toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4- oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4- pentadienoate, 3-butene-lol or 1,3-butadiene.
• [EN] MICROORGANISMS AND METHODS FOR THE PRODUCTION OF 1.4- CYCLOHEXANEDIMETHANOL<br/>[FR] MICROORGANISMES ET PROCÉDÉS POUR LA PRODUCTION DE 1,4-CYCLOHEXANEDIMÉTHANOL
  申请人：GENOMATICA INC

  公开号：WO2012082978A1

  公开（公告）日：2012-06-21

  A non-naturally occurring microbial organism includes a microbial organism having a 1,4-cyclohexanedimethanol pathway that includes at least one exogenous nucleic acid encoding a 1,4-cyclohexanedimethanol pathway enzyme expressed in a sufficient amount to produce 1,4- cyclohexanedimethanol. A method for producing 1,4-cyclohexanedimethanol includes culturing a non-naturally occurring microbial organism having a 1,4-cyclohexanedimethanol pathway. The pathway includes at least one exogenous nucleic acid encoding a 1,4- cyclohexanedimethanol pathway enzyme expressed in a sufficient amount to produce 1,4- cyclohexanedimethanol, under conditions and for a sufficient period of time to produce 1,4- cyclohexanedimethanol.